medigraphic.com
Academia Mexicana de Neurología, A.C.

2009, Number 5

<< Back Next >>

Rev Mex Neuroci 2009; 10 (5)

Obstacles and recommendations for the treatment of abusers/addicted to psychotropic

Souza MM

Language: Spanish
References: 42
Page: 350-359
PDF size: 84.16 Kb.


ABSTRACT

We review the major obstacles that limit access to treatment programmes (TP), Substance Abuse Disorders (SAD), in patients with abuse/dependence on psychotropic substances, based on the data produced by contemporary literature. This brief description illustrates a group of institutional activities inherent to services, plannification-action and personnel from diagnosis to a longterm rehabilitation, which traditionally have been identified as a recommendation for achieving the operational improvement of the health personnel (HP), for the sake of building a more effective tool for professional work based on the doctor-patient relationship. There are recommendations on amendments to the institutional framework and operational HP, working in these units, focusing on obtaining a positive and respectful; shows confidence; minimizing the power structure that allows a relationship productive during and after the TP, to help redefine a new positive Ego, in order to model a healthy lifestyle; spontaneity, objectivity, projecting confidence, sense of humor show, without confrontation and encourage openness to develop a warm relationship and support to patients in their care. It stresses the importance of preventing relapses and family participation in the management, to encourage therapeutic adherence, and some patterns suitable for the amendment of TP emphasizing the principles, values and treatment guidelines.


REFERENCES

  1. Souza y MM. Enseñanza e investigación sobre adicciones en CD de México. Psiquiatría 1998; 2a. Época. 14(3): 100-6.

  2. Souza y MM. Adicciones: clínica y terapéutica. México: Ed. Alfil; 2007.

  3. Souza y MM. El papel de la mitología popular, la semántica y la iatrogenia en las adicciones. Rev Mex Neuroci 2001; 2(1): 25-7.

  4. 4, Souza y Machorro M, Guisa CVM, Díaz BSL. Hacia una integración nacional de la terapéutica antiadictiva. Rev Mex Neuroci 2005; 6(5): 411-25.

  5. Souza y MM, Quijano BEM, Romero RR, Arroyo PF, Quintanilla BJ. Glosario lexicológico de adicciones para personal de salud. Rev Mex Neuroci 2005.

  6. Souza y MM, Guisa CVM, Díaz BSL. Hacia una integración nacional de la terapéutica antiadictiva. Rev Mex Neuroci 2005.

  7. Adlaf EM, Ivis FJ, Smart RG. Ontario Student Drug Use Survey 1977- 1997. Toronto, Canada: Addiction Research Foundation; 1997.

  8. Health Canada. Canada’s Drug Strategy. Ottawa: Minister of Public Works and Government Services, Cat. #H39-440/1998E. 1998, p. 9.

  9. Varcoe C. From Better Than Nothing to Best Practices: a background paper on best practices in health care in relation to violence against women. Victoria. Ministry Advisory Council on Women’s Health, British Columbia Ministry of Health; 1998, p. 4.

  10. Spooner C, Howard J, Mattick R. The Nature and Treatment of Adolescent Substance Abuse: Final Report of the Adolescent Treatment Research Project. New South Wales, Australia: National Drug and Alcohol Research Centre. 1996.

  11. Azrin NH, Donahoe B, Kogan E, Bisalel V, Acierno R. Youth drug abuse treatment: a controlled outcome study. J Child Substance Abuse 1994; 3(3): 1-16.

  12. Souza y MM. Dinámica y evolución de la vida en pareja. México: El Manual Moderno; 1996.

  13. Souza y Machorro M. Educación en Salud Mental para Maestros. México: El Manual Moderno; 1988.

  14. Puente SF, Gómez MF, Souza y Machorro M, Espel MA. La familia ante el problema de las drogas. 2a. Ed. Centro Mexicano de Estudios en Salud Mental. México: CEMESAM; 1986.

  15. PNUFID. Programa de las Naciones Unidas para la Fiscalización Internacional de Drogas. Manual sobre Tratamiento del Abuso de Drogas. Tratamiento contemporáneo del abuso de drogas: Análisis de las pruebas científicas. Nueva York: Organización de las Naciones Unidas; 2003.

  16. Souza y MM, Cruz MDL, Díaz Barriga SL, Guisa CVM. Acerca de los criterios rectores de la terapéutica antiadictiva. Subdirección de Hospitalización y Proyectos Clínicos. México: Centros de Integración Juvenil, A.C.: 2007.

  17. Oficina de las Naciones Unidas contra la Droga y el Delito (ONUDD). Abuso de drogas: tratamiento y rehabilitación. Guía de planificación y aplicación. Cap. VI. Integración efectiva de los servicios de tratamiento. Viena: Naciones Unidas; 2003.

  18. Souza y MM. Psiquiatría de las adicciones y la profesionalización de la terapéutica antiadictiva. Simposio Centros de Integración Juvenil, A.C. Retos Actuales en la Atención Profesional de las Adicciones. XX Congreso Nacional de la Asociación Psiquiátrica Mexicana, A.C. “Psiquiatría Compromiso Social”. Hotel Hyatt, Mérida, Yuc. Nov. 16- 19, 2007.

  19. Souza y MM, Díaz Barriga SL, Guisa CVM. Criterios derivativos para la referencia y tratamiento de abusadores/adictos a psicotrópicos Subdirección de Hospitalización y Proyectos Clínicos. México: Centros de Integración Juvenil, A.C.; 2006.

  20. American Society of Addiction Medicine, ASAM. Public policy statement on screening for addiction in primary care settings. ASAM News 1997; 17: 17-18.

  21. Mclellan AT, Mckay JR, Forman R, Cacciola J, Kemp J. Reconsidering the evaluation of addiction treatment: from retrospective follow-up to concurrent recovery monitoring. Addiction 2005; 100: 447-58.

  22. SAMHSA. Substance Abuse and Mental Health Services Administration. Office of Applied Studies. National Survey of Substance Abuse Treatment Services (N-SSATS): 2000 Data on Substance Abuse Treatment Facilities, DHHS publication no. SMA 02-3668. Rockville, MD: US Government Printing Office. SAMHSA, 2002.

  23. Souza y Machorro M. Nosología y Propedéutica de los Programas Antiadictivos. Rev Mex Neuroci 2005; 6(2): 166-79.

  24. Souza y Machorro M, Quijano BEM, Romero RR, Arroyo PF, García RL, Quintanilla BJ, Díaz Barriga SL, Guisa CVM. Residencia Diurna: una alternativa clínica para pacientes abusadores/adictos a psicotrópicos. Rev Mex Neuroci 2006; 7(4): 308-24.

  25. Souza y Machorro M, Guisa CVM, Díaz BSL. TDAH y su comorbilidad adictiva. Rev Mex Neuroci 2005; 6(3): 227-44.

  26. Souza y Machorro M. Trastorno por consumo de sustancias y su comorbilidad depresiva. Rev Mex Neuroci 2007; 8(1): 67-70.

  27. Souza y Machorro M. Filosofía y políticas de los programas terapéuticos contra las adicciones. Subdirección de Hospitalización y Proyectos Clínicos. México: Centros de Integración Juvenil, A.C.; 2005.

  28. Ho AP, Tsuang JW, Liberman RP. Achieving effective treatment of patients with chronic psychotic and comorbid substance dependence. Am J Psychiatry 1999; 156: 1765-70.

  29. Heinrich CJ, Lynn LE. Improving the organization, management, and outcomes of substance abuse treatment programs. Am J Drug Alcohol Abuse 2002; 4: 601-22.

  30. SPM. Del cuánto al por qué: la utilización de los servicios de salud desde la perspectiva de los usuarios. Sal Púb Méx 1997; 39(5): 73- 82.

  31. Thall PF, Millikan RE, Sung H. Evaluating multiple treatment courses in clinical trials. Statistics in Medicine 2000; 19: 1011-28.

  32. UK Health Department. Models of care for substance misuse treatment. Promoting quality, efficiency and effectiveness of treatment services. London: 2002.

  33. Rounds-Bryant JL, Kristiansen PL, Hubbard RL. Drug abuse treatment outcome study of adolescents: a comparison of client characteristics and pre-treatment behaviours in three treatment modalities. Am J Drug Alcohol Abuse 1999; 25: 573-91.

  34. Guisa CVM, Díaz BSL, Souza y Machorro M. A propósito de la relación entre adicciones y delincuencia. Psiquiatría 2003; 19(1): 14-27.

  35. Spooner C, Howard J, Mattick R. The Nature and Treatment of adolescent substance abuse: final report of the Adolescent Treatment Research Project. New South Wales, Australia: National Drug and Alcohol Research Centre; 1996.

  36. Souza y Machorro M. Adicciones, psicopatología y psicoterapia. Rev Mex Neuroci 2004; 5(1): 57-69.

  37. Faist R, Harvey-Jansen Z. Adolescent Alcohol and Drug Treatment Effectiveness: a literature review. Alberta: Alberta Alcohol and Drug Commission; 1994.

  38. Chinman MJ, Linney JA. Toward a model of adolescent empowerment: theoretical and empirical evidence. J Primary Prevention 1998; 18(4): 393-413.

  39. Bergmann PE, Smith MB, Hoffman NG. Adolescent treatment: implications for assessment, practice guidelines and outcome management. Pediatric Clinics of North Am 1995; 42(2): 453-72.

  40. Joanning H, Quinn W, Thomas F, Mullen R. Treating adolescent drug abuse: a comparison of family systems therapy, group therapy and family drug education. J Marital Family Therapy 1992; 18(4): 345-56.

  41. Feigelman W, Hyman M, Amann K. Daycare treatment for youth multiple drug abuse: a six year follow-up study. J Psychiatric Drugs 1988; 20(4): 385-95.

  42. Prochaska JO, Diclemente CC, Norcross JC. In search of how people change: applications to addictive behaviors. Am Psychol 1992; 47: 1102-14.




2020     |     www.medigraphic.com